Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A nationwide pilot study on breast cancer screening in Peru.
Araujo JM, Gómez AC, Jongh WZ, Ausejo J, Córdova I, Schwarz LJ, Bretel D, Fajardo W, Saravia-Huarca LG, Barboza-Meca J, Morante Z, Guillén JR, Gómez H, Cárdenas NK, Hernández L, Melo W, Villarreal-Garza C, Caglevic C, Palacio C, García H, Mejía G, Flores C, Vallejos C, Pinto JA. Araujo JM, et al. Among authors: flores c. Ecancermedicalscience. 2023 Jan 9;17:1494. doi: 10.3332/ecancer.2023.1494. eCollection 2023. Ecancermedicalscience. 2023. PMID: 36816782 Free PMC article.
Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival.
Gómez HL, Samanéz C, Campana F, Neciosup SP, Vera L, Casanova L, Leon J, Flores C, de Mendoza FH, Casteñeda CA, Pinto JA, Vallejos CS. Gómez HL, et al. Among authors: flores c. Hematol Oncol Stem Cell Ther. 2012;5(3):152-7. doi: 10.5144/1658-3876.2012.152. Hematol Oncol Stem Cell Ther. 2012. PMID: 23095791 Free article. Clinical Trial.
MGMT promoter methylation in Peruvian patients with glioblastoma.
Belmar-Lopez C, Castaneda CA, Castillo M, García-Corrochano P, Orrego E, Meléndez B, Casavilca S, Flores C, Orrego E. Belmar-Lopez C, et al. Among authors: flores c. Ecancermedicalscience. 2018 Feb 14;12:812. doi: 10.3332/ecancer.2018.812. eCollection 2018. Ecancermedicalscience. 2018. PMID: 29515653 Free PMC article.
Barriers in Latin America for the management of locally advanced breast cancer.
Pinto JA, Pinillos L, Villarreal-Garza C, Morante Z, Villarán MV, Mejía G, Caglevic C, Aguilar A, Fajardo W, Usuga F, Carrasco M, Rebaza P, Posada AM, Tirado-Hurtado I, Flores C, Vallejos CS. Pinto JA, et al. Among authors: flores c. Ecancermedicalscience. 2019 Jan 22;13:897. doi: 10.3332/ecancer.2019.897. eCollection 2019. Ecancermedicalscience. 2019. PMID: 30792814 Free PMC article. Review.
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
Saravia CH, Flores C, Schwarz LJ, Bravo L, Zavaleta J, Araujo J, Neciosup S, Pinto JA. Saravia CH, et al. Among authors: flores c. Clin Med Insights Oncol. 2019 Aug 9;13:1179554919868482. doi: 10.1177/1179554919868482. eCollection 2019. Clin Med Insights Oncol. 2019. PMID: 31447598 Free PMC article.
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
Morante Z, Ruiz R, Araujo JM, Pinto JA, Cruz-Ku G, Urrunaga-Pastor D, Namuche F, Flores C, Mantilla R, Luján MG, Fuentes H, Schwarz L, Aguilar A, Neciosup S, Gómez HL. Morante Z, et al. Among authors: flores c. Clin Breast Cancer. 2021 Jun;21(3):239-246.e4. doi: 10.1016/j.clbc.2020.09.008. Epub 2020 Sep 18. Clin Breast Cancer. 2021. PMID: 33221201
1,287 results